Growth Drivers
Frequency of Cardiovascular Diseases Among the Geriatric Population
The renin inhibitor market is estimated to observe a significant growth on account of the frequency of cardiovascular diseases among the geriatric population as aged individuals continue to become prone to hypertension and other cardiovascular complications. Additionally, an individual who suffers from hypertension is very susceptible to other complications such as aneurysm and heart failure. Thus, requires early diagnosis as well as management by using renin inhibitor drugs.
Rampant Research and Development for the Antihypertensive Drugs Driving the Global Market
An upsurge in research related to antihypertensive drugs in developing economies coupled with pulmonary hypertensive practices offering training programs for people, a high predominance of incessant illness, initiatives are taken by the government and the growing commonness of hypertension in youth population in emerging economies are anticipated to fuel the growth of renin inhibitor over the forecast period., i.e. 2020-2028.
Challenges
Side Effects of Renin Inhibitors
Growth of renin inhibitor is expected to be hampered by the side effects of drugs such as cough, diarrhea, nervousness, constipation, dizziness, weakness, and increased risk of genericization coupled with recent patent expirations.
Base Year |
2023 |
Forecast Year |
2024–2036 |
Regional Scope |
|
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?